Copyright
©The Author(s) 2023.
World J Diabetes. Jun 15, 2023; 14(6): 741-757
Published online Jun 15, 2023. doi: 10.4239/wjd.v14.i6.741
Published online Jun 15, 2023. doi: 10.4239/wjd.v14.i6.741
Figure 1 Possible pathomechanisms leading to the development of diabetic neuropathy.
For further information, see text. PKC: Protein kinase C; T2DM: Type 2 DM diabetes mellitus; ROS: Reactive oxygen species; AGE: Advanced glycation end product; FFA: Food and Drug Administration; NADP: Nicotinamide adenine dinucleotide phosphate.
- Citation: Ismail CAN. Issues and challenges in diabetic neuropathy management: A narrative review. World J Diabetes 2023; 14(6): 741-757
- URL: https://www.wjgnet.com/1948-9358/full/v14/i6/741.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i6.741